The association of the r219k polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia

Journal of Molecular Medicine

Volumn 81, Issue 4, 2003, Pages 264-270

  Evans, David ^a   Beil, F Ulrich ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ATP binding cassette transporter 1; Coronary heart disease; Plasma lipids; Polymorphism

Indexed keywords

ABC TRANSPORTER; ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE CASSETTE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; R219K POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0038583684     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0426-y     Document Type: Article

References (23)

1. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219
2. Hayden MR, Clee SM, Brooks-Wilson A, Genest J, Attie A, Kastelein JJP (2000) Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr Opin Lipidol 11:117-122
3. Schmitz G, Kaminski WE, Orso E (2000) ABC transporters in cellular lipid trafficking. Curr Opin Lipidol 11:493-501
4. Oram JF, Lawn RM (2001) ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42:1173-1179
5. Oram JF (2002) ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol 13:373-381
6. Modzioch M, Orso E, Klucken J, Langmann T, Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C, Porsch-Özcürümez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351
7. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HOF, Loubser O, Oulette BFF, Fichter K, Ashbourne-Excoffon KJD, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Koop B, Pimstone S, Kastelein JJP, Genest J, Hayden MR (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345
8. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette J, Deleuze J, Brewer HB, Duverger N, Denefle P, Assmann G (1999) Tangier disease is caused by mutation in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-355
9. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, Collins JA, van Dam M, Molhuizen HOF, Loubser O, Oulette BFF, Sensen CW, Fichter K, Mott S, Denis M, Martindale D, Boucher B, Pimstone S, Genest J, Kastelein JJP, Hayden MR (1999) Mutations in the ABCA1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 354:1341-1346
10. Clee SM, Kastelein JJP, van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stule T, Suda T, Ceska R, Boucher B, Rondeau C, DeSouich C, Brooks-Wilson A, Molhuizen HOF, Frohlich J, Genest J, Hayden MR (2000) Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106:1263-1270
11. Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ, Freeman MW (2000) Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 41:1125-1135
12. Mott S, Yu L, Marcil M, Boucher B, Rondeau C, Genest J (2000) Decreased cellular cholesterol afflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Atherosclerosis 152:457-468
13. Wang J, Burnett JR, Near S, Young K, Zinman B, Hanley AJG, Connelly PW, Harris SB, Hegle RA (2000) Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 20:1983-1989
14. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aouizerat BE, Cho MH, Fielding CJ, Kane JP (2000) Analysis of the hABC1 gene 5′end: Additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun 271:451-455
15. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HOF, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J, Kastelein JJP, Hayden MR (2001) Common genetic variation in the ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198-1205
16. Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, Ordovas JM, Aslanidis C, Lackner KJ, Bloomfield H, Collins D, Robins SJ, Wilson PW, Schmitz G (2001) Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol and coronary heart disease. Atherosclerosis 154:607-611
17. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM, Marian AJ (2001) Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88:969-973
18. Zwarts KY, Clee SM, Zwinderman AH, Engert JC, Singaraja R, Loubser O, James E, Roomp K, Hudson TJ, Jukema JW, Kastelein JJP, Hayden MR (2002) ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61:115-125
19. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud P (1995) A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 15:468-478
20. Zhang H, Reymer PWA, Liu MS, Forsythe IJ, Groenemeyer BE, Frohlich J, Brunzell JD, Kastelein JJP, Hayden MR, Ma Y (1995) Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn291→Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 15:1695-1703
21. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31:545-548
22. Danesh J, Collins R, Peto R (2000) Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102:1082-1085
23. Talmud PJ (2001) Genetic determinants of plasma triglycerides: impact of rare and common mutations. Curr Atheroscl Rep 3:191-199